• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白和柠檬酸盐对草酸钙结晶的分子调节作用

Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.

作者信息

Qiu S R, Wierzbicki A, Orme C A, Cody A M, Hoyer J R, Nancollas G H, Zepeda S, De Yoreo J J

机构信息

Department of Chemistry and Materials Science, Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, CA 94551, USA.

出版信息

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1811-5. doi: 10.1073/pnas.0307900100. Epub 2004 Feb 6.

DOI:10.1073/pnas.0307900100
PMID:14766970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC357009/
Abstract

Calcium oxalate monohydrate (COM), which plays a functional role in plant physiology, is a source of chronic human disease, forming the major inorganic component of kidney stones. Understanding molecular mechanisms of biological control over COM crystallization is central to development of effective stone disease therapies and can help define general strategies for synthesizing biologically inspired materials. To date, research on COM modification by proteins and small molecules has not resolved the molecular-scale control mechanisms. Moreover, because proteins directing COM inhibition have been identified and sequenced, they provide a basis for general physiochemical investigations of biomineralization. Here, we report molecular-scale views of COM modulation by two urinary constituents, the protein osteopontin and citrate, a common therapeutic agent. Combining force microscopy with molecular modeling, we show that each controls growth habit and kinetics by pinning step motion on different faces through specific interactions in which both size and structure determine the effectiveness. Moreover, the results suggest potential for additive effects of simultaneous action by both modifiers to inhibit the overall growth of the crystal and demonstrate the utility of combining molecular imaging and modeling tools for understanding events underlying aberrant crystallization in disease.

摘要

一水合草酸钙(COM)在植物生理学中发挥着功能性作用,却是人类慢性疾病的一个源头,它构成了肾结石的主要无机成分。了解生物对COM结晶进行控制的分子机制是开发有效的结石疾病疗法的核心,并且有助于确定合成受生物启发材料的通用策略。迄今为止,关于蛋白质和小分子对COM修饰的研究尚未解析分子尺度的控制机制。此外,由于已鉴定并测序了指导COM抑制的蛋白质,它们为生物矿化的一般物理化学研究提供了基础。在此,我们报告了两种尿液成分——蛋白质骨桥蛋白和常见治疗剂柠檬酸盐对COM进行调节的分子尺度观点。通过将力显微镜与分子建模相结合,我们表明它们各自通过特定相互作用固定不同晶面上的台阶运动来控制生长习性和动力学,在这些相互作用中,尺寸和结构都决定了有效性。此外,结果表明两种修饰剂同时作用产生累加效应以抑制晶体整体生长的可能性,并证明了结合分子成像和建模工具对于理解疾病中异常结晶背后事件的实用性。

相似文献

1
Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.骨桥蛋白和柠檬酸盐对草酸钙结晶的分子调节作用
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1811-5. doi: 10.1073/pnas.0307900100. Epub 2004 Feb 6.
2
Molecular modulation of calcium oxalate crystallization.草酸钙结晶的分子调控
Am J Physiol Renal Physiol. 2006 Dec;291(6):F1123-31. doi: 10.1152/ajprenal.00136.2006.
3
Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.分子修饰物揭示了病理性晶体生长抑制的机制。
Nature. 2016 Aug 25;536(7617):446-50. doi: 10.1038/nature19062. Epub 2016 Aug 17.
4
Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps.柠檬酸盐通过选择性结合原子台阶对一水合草酸钙结晶的调控
J Am Chem Soc. 2005 Jun 29;127(25):9036-44. doi: 10.1021/ja043591s.
5
Mechanistic Pathways for the Molecular Step Growth of Calcium Oxalate Monohydrate Crystal Revealed by In Situ Liquid-Phase Atomic Force Microscopy.原位液相原子力显微镜揭示一水合草酸钙晶体分子逐步生长的机理途径。
ACS Appl Mater Interfaces. 2021 Aug 11;13(31):37873-37882. doi: 10.1021/acsami.1c09245. Epub 2021 Jul 30.
6
The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.在人工尿液中,骨桥蛋白控制一水草酸钙单水合物形态的转变,为研究乳头状肾结石的形成提供了思路。
Colloids Surf B Biointerfaces. 2016 Oct 1;146:296-306. doi: 10.1016/j.colsurfb.2016.06.030. Epub 2016 Jun 16.
7
In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.水提取物对体外草酸钙结晶动力学和晶体形态的影响:潜在抗结石机制分析。
PLoS One. 2019 Jun 25;14(6):e0218734. doi: 10.1371/journal.pone.0218734. eCollection 2019.
8
Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.草酸钙晶体表面的黏附作用及尿液成分的影响。
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):267-72. doi: 10.1073/pnas.0406835101. Epub 2004 Dec 29.
9
Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.晶内蛋白质与尿石症:一水草酸钙和二水草酸钙晶体蛋白质含量及超微结构的比较
BJU Int. 2005 Sep;96(4):654-63. doi: 10.1111/j.1464-410X.2005.05701.x.
10
Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.透钙磷石晶体在草酸钙结晶中的双重作用为肾结石形成提供了物理化学机制。
Kidney Int. 2006 Jul;70(1):71-8. doi: 10.1038/sj.ki.5000424. Epub 2006 Apr 26.

引用本文的文献

1
Bio-inspired multifunctional disruptors of calcium oxalate crystallization.受生物启发的草酸钙结晶多功能干扰剂。
Nat Commun. 2025 Jun 5;16(1):5229. doi: 10.1038/s41467-025-60320-4.
2
Biomimetic Growth of Calcium Oxalate Hydrates: Shape Development and Structures in Agar Gel Matrices.草酸钙水合物的仿生生长:琼脂凝胶基质中的形状发展与结构
Chemistry. 2025 May;31(25):e202404269. doi: 10.1002/chem.202404269. Epub 2025 Apr 14.
3
In vivo glycation-interplay between oxidant and carbonyl stress in bone.骨中氧化剂与羰基应激之间的体内糖基化相互作用。
JBMR Plus. 2024 Aug 8;8(11):ziae110. doi: 10.1093/jbmrpl/ziae110. eCollection 2024 Nov.
4
Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization.塔托酸作为病理性草酸钙结晶潜在抑制剂的研究。
Adv Sci (Weinh). 2024 Jun;11(21):e2400642. doi: 10.1002/advs.202400642. Epub 2024 Apr 22.
5
Material and nanomechanical properties of bone structural units of cortical and trabecular iliac bone tissues from untreated postmenopausal osteoporotic women.未经治疗的绝经后骨质疏松症女性的皮质和小梁髂骨组织骨结构单元的材料和纳米力学特性
Bone Rep. 2022 Sep 29;17:101623. doi: 10.1016/j.bonr.2022.101623. eCollection 2022 Dec.
6
Shape and structure controlling of calcium oxalate crystals by a combination of additives in the process of biomineralization.生物矿化过程中添加剂组合对草酸钙晶体形状和结构的控制
RSC Adv. 2018 Mar 20;8(20):11014-11020. doi: 10.1039/c8ra00661j. eCollection 2018 Mar 16.
7
Liquid-Liquid Phase Separation in Nucleation Process of Biomineralization.生物矿化成核过程中的液-液相分离
Front Chem. 2022 Feb 4;10:834503. doi: 10.3389/fchem.2022.834503. eCollection 2022.
8
Ion Pathways in Biomineralization: Perspectives on Uptake, Transport, and Deposition of Calcium, Carbonate, and Phosphate.生物矿化中的离子通道:对钙、碳酸盐和磷酸盐的摄取、运输和沉积的研究进展。
J Am Chem Soc. 2021 Dec 22;143(50):21100-21112. doi: 10.1021/jacs.1c09174. Epub 2021 Dec 9.
9
Nucleation kinetics of calcium oxalate monohydrate as a function of pH, magnesium, and osteopontin concentration quantified with droplet microfluidics.用微滴微流控技术定量研究一水草酸钙的成核动力学与pH值、镁及骨桥蛋白浓度的关系。
Biomicrofluidics. 2021 Nov 22;15(6):064103. doi: 10.1063/5.0063714. eCollection 2021 Dec.
10
Intrinsically Disordered Osteopontin Fragment Orders During Interfacial Calcium Oxalate Mineralization.内在无序骨桥蛋白片段在界面草酸钙矿化过程中有序排列。
Angew Chem Int Ed Engl. 2021 Aug 16;60(34):18577-18581. doi: 10.1002/anie.202105768. Epub 2021 Jul 16.

本文引用的文献

1
Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation.分子与草酸钙晶体之间的粘附:肾结石形成中的关键相互作用。
J Am Chem Soc. 2003 Mar 12;125(10):2854-5. doi: 10.1021/ja029575h.
2
Calcium oxalate in plants.植物中的草酸钙。
Trends Plant Sci. 2001 Jul;6(7):331. doi: 10.1016/s1360-1385(01)02014-3.
3
Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.磷酸化骨桥蛋白肽通过抑制草酸钙晶体的生长来抑制结晶。
Kidney Int. 2001 Jul;60(1):77-82. doi: 10.1046/j.1523-1755.2001.00772.x.
4
Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin.SIBLING蛋白、骨唾液酸蛋白和骨桥蛋白的柔性结构。
Biochem Biophys Res Commun. 2001 Jan 19;280(2):460-5. doi: 10.1006/bbrc.2000.4146.
5
Thermodynamics of calcite growth: baseline for understanding biomineral formation.方解石生长的热力学:理解生物矿化形成的基础
Science. 1998 Oct 23;282(5389):724-7. doi: 10.1126/science.282.5389.724.
6
Contribution of human uropontin to inhibition of calcium oxalate crystallization.人尿桥蛋白对草酸钙结晶抑制作用的贡献。
Kidney Int. 1998 Jan;53(1):194-9. doi: 10.1046/j.1523-1755.1998.00739.x.
7
Scanning electron microscopic study of the effect of citrate and pyrophosphate on calcium oxalate crystal morphology.柠檬酸盐和焦磷酸盐对草酸钙晶体形态影响的扫描电子显微镜研究
J Urol. 1993 Dec;150(6):1980-3. doi: 10.1016/s0022-5347(17)35950-5.
8
Osteopontin inhibits nucleation of calcium oxalate crystals.骨桥蛋白抑制草酸钙晶体的成核。
Ann N Y Acad Sci. 1995 Apr 21;760:375-7. doi: 10.1111/j.1749-6632.1995.tb44661.x.
9
Osteopontin in urinary stone formation.骨桥蛋白在尿路结石形成中的作用
Ann N Y Acad Sci. 1995 Apr 21;760:257-65. doi: 10.1111/j.1749-6632.1995.tb44636.x.
10
Citrate and renal calculi: an update.柠檬酸盐与肾结石:最新进展
Miner Electrolyte Metab. 1994;20(6):371-7.